Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells

Journal of Endocrinology

Volumn 214, Issue 1, 2012, Pages 31-43

  Vignozzi, Linda ^a,b   Cellai, Ilaria ^a,b   Santi, Raffaella ^a   Lombardelli, Letizia ^c   Morelli, Annamaria ^a,b   Comeglio, Paolo ^a,b   Filippi, Sandra ^a   Logiodice, Federica ^c   Carini, Marco ^a   Nesi, Gabriella ^a   Gacci, Mauro ^a   Piccinni, Marie Pierre ^c   Adorini, Luciano ^d   Maggi, Mario ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CIRMAR Centro Interuniversitario di Ricerca sulle basi molecolari della Malattie della Riproduzione   (Italy)

^c Immunoallergology Unit   (Italy)

^d INTERCEPT PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFECT; HUMAN; HUMAN CELL; HYPOGONADISM; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY INFILTRATE; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; STROMA CELL;

AGED; AGED, 80 AND OVER; ANDROGENS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; COHORT STUDIES; CYCLOOXYGENASE 2; CYTOKINES; DIHYDROTESTOSTERONE; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOCYTE ACTIVATION; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; PROSTATIC HYPERPLASIA; RECEPTORS, ANDROGEN; TESTOSTERONE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864296846     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0142     Document Type: Article

References (46)

1. Asirvatham AJ, Schmidt M, Gao B & Chaudhary J 2006 Androgens regulate the immune/inflammatory response and cell survival pathways in rat ventral prostate epithelial cells. Endocrinology 147 257-271.
2. Azadzoi KM, Tarcan T, Siroky MB & Krane RJ 1999 Atherosclerosis-induced chronic ischemia causes bladder fibrosis and non-compliance in the rabbit. Journal of Urology 161 1626-1635.
3. Bartsch W, Klein H, Schiemann U, Bauer HW & Voigt KD 1990 Enzymes of androgen formation and degradation in the human prostate. Annals of the New York Academy of Sciences 595 53-66.
4. Buvat J, Maggi M, Gooren L, Guay AT, Kaufman JM, Morgentaler A, Schulman C, Tan HM, Torres LO, Yassin A et al. 2010 Endocrine aspects of male sexual dysfunctions. Journal of Sexual Medicine 7 1627-1656.
5. Crescioli C, Maggi M, Vannelli GB, Luconi M, Salerno R, Barni T, Gulisano M, Forti G & Serio M 2000 Effect of a vitamin D3 analog on keratinocyte growth factor-induced cell proliferation in benign prostate hyperplasia. Journal of Clinical Endocrinology and Metabolism 85 2576-2583.
6. Crescioli C, Ferruzzi P, Caporali A, Mancina R, Comerci A, Muratori M, Scaltriti M, Vannelli GB, Smiroldo S, Mariani R et al. 2003 Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog. Endocrinology 144 3046-3057.
7. De Lean A, Munson PJ & Rodbard D 1978 Simultaneous analysis of famiglie of sigmoidal curves: application to biomassa, radioligand assay, and physiological dose-response curves. American Journal of Physiology 235 97-102.
8. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Grönberg H, Drake CG, Nakai Y, Isaacs WB & Nelson WG 2007 Inflammation in prostate carcinogenesis. Nature Reviews. Cancer 7 256-269.
9. Desai KV, Michalowska AM, Kondaiah P, Ward JM, Shih JH & Green JE 2004 Gene expression profiling identifies a unique androgen-mediated inflammatory/ immune signature and aPTEN(phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostate. Molecular Endocrinology 18 2895-2907.
10. Fibbi B, Morelli A, Vignozzi L, Filippi S, Chavalmane A, De Vita G, Marini M, Gacci M, Vannelli GB, Sandner P et al. 2010a Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. Journal of Sexual Medicine 7 59-69.
11. Fibbi B, Penna G, Morelli A, Adorini L & Maggi M 2010bChronic inflammation in the pathogenesis of benign prostatic hyperplasia. International Journal of Andrology 33 475-488.
12. Filippi S, Vignozzi L, Morelli A, Chavalmane AK, Sarchielli E, Fibbi B, Saad F, Sandner P, Ruggiano P, Vannelli GB et al. 2009 Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. Journal of Sexual Medicine 6 3274-3288.
13. Hatakeyama H, Nishizawa M, Nakagawa A, Nakano S, Kigoshi T & Uchida K 2002 Testosterone inhibits tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells. FEBS Letters 530 129-132.
14. Isaacs JT, Brendler CB & Walsh PC 1983 Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate. Journal of Clinical Endocrinology and Metabolism 56 139-146.
15. Issa MM & Regan TS 2007 Medical therapy for benign prostatic hyperplasia - present and future impact. American Journal of Managed Care 1 S4-S9.
16. Kanai T, Nemoto Y, Kamada N, Totsuka T, Hisamatsu T, Watanabe M & Hibi T 2009 Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease. Current Opinion in Gastroenterology 25 306-313.
17. Kozlowski R, Kershen RT, Siroky MB, Krane RJ & Azadzoi KM 2001 Chronic ischemia alters prostate structure and reactivity in rabbits. Journal of Urology 165 1019-1026.
18. Krajewska M, Banares S, Zhang EE, Huang X, Scadeng M, Jhala US, Feng GS & Krajewski S 2008 Development of diabesity in mice with neuronal deletion of Shp2 tyrosine phosphatase. American Journal of Pathology 172 1312-1324.
19. Kramer G, Mitteregger D & Marberger M 2007 Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? European Urology 51 1202-1216.
20. Lédée N, Lombroso R, Lombardelli L, Selva J, Dubanchet S, Chaouat G, Frankenne F, Foidardart JM, Maggi E, Romagnani S et al. 2008 Cytokines and cemokines in follicular fluids and potential of the corresponding embryo: the role of granulocyte colony-stimulating factor. Human Reproduction 23 2001-2009.
21. Liao W, Lin JX & Leonard WJ 2011 IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Current Opinion in Immunology 23 598-604.
22. Liu CC, Huang SP, Li WM, Wang CJ, Chou YH, Li CC, Huang CH & Wu WJ 2007 Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men. Urology 70 677-680.
23. Liu X, Leung S, Wang C, Tan Z, Wang J, Guo TB, Fang L, Zhao Y, Wan B, Qin X et al. 2010 Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nature Medicine 16 191-197.
24. Lotti F, Corona G, Colpi GM, Filimberti E, Degli Innocenti S, Mancini M, Baldi E, Noci I, Forti G, Adorini L et al. 2011 Elevated body mass index correlates with higher seminal plasma interleukin 8 levels and ultrasonographic abnormalities of the prostate in men attending an andrology clinic for infertility. Journal of Endocrinological Investigation 34 336-342.
25. Meng J, Mostaghel EA, Vakar-Lopez F, Montgomery B, True L & Nelson PS 2011 Testosterone regulates tight junction proteins and influences prostatic autoimmune responses. Hormones & Cancer 2 145-156.
26. Morelli A, Comeglio P, Filippi S, Sarchielli E, Cellai I, Vignozzi L, Yehiely-Cohen R, Maneschi E, Gacci M, Carini M et al. 2012 Testosterone and farnesoid X receptor agonist INT-747 ounteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome. Journal of Steroid Biochemistry and Molecular Biology (http://dx.doi.org/10.1016/j.jsbmb.2012.02.007).
27. Nickel JC, True LD, Krieger JN, Berger RE, Boag AH, Young ID & participating members of the North American Chronic Prostatitis Collaborative Research Network and the International Prostatitis Collaborative Network 2001 Consensus development of a histopathological classification system for chronic prostatic inflammation. British Journal of Urology International 87 797-805.
28. Nickel JC, Roehrborn CG, O'leary MP, Bostwick DG, Somerville MC & Rittmaster RS 2007 Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial. Journal of Urology 178 896-900.
29. Nickel JC, Roehrborn CG, O'Leary MP, Bostwick DG, Somerville MC & RittmasterRS2008The relationship between prostate inflammationandlower urinary tract symptoms: examination of baseline data fromtheREDUCE trial. European Urology 54 1379-1384.
30. Norata GD, Tibolla G, Seccomandi PM, Poletti A & Catapano AL 2006 Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide- induced inflammatory response in human endothelial cells. Journal of Clinical Endocrinology andMetabolism 91 546-554.
31. Penna G, Mondaini N, Amuchastegui S, Degli Innocenti S, Carini M, Giubilei G, Fibbi B, Colli E, Maggi M & Adorini L 2007 Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. European Urology 51 524-533.
32. Penna G, Fibbi B, Amuchastegui S, Corsiero E, Laverny G, Silvestrini E, Chavalmane A, Morelli A, Sarchielli E, Vannelli GB et al. 2009 The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways. Prostate 69 480-493.
33. Piccinni MP, GiudiziMG, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, Parronchi P, Manetti R, Annunziato F, Livi C et al. 1995 Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. Journal of Immunology 155 128-133.
34. Quintar AA, Roth FD, De Paul AL, Aoki A & Maldonado CA 2006 Toll-like receptor 4 in rat prostate: odulation by testosterone and acute bacterial infection in epithelial and stromal cells. Biology of Reproduction 75 664-672.
35. Robinette CL 1988 Sex-hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate. Prostate 12 271-286.
36. Roehrborn CG, Nuckolls JG, Wei JT & Steers W 2007 BPH Registry and Patient Survey Steering Committee. The benign prostatic hyperplasia registry and patient survey: study design, methods and patient baseline characteristics. BJU International 100 813-819.
37. Ropiquet F, GiriD, LambDJ&IttmannM1999 FGF7 andFGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation. Journal of Urology 162 595-599.
38. Rotondi M, Chiovato L, Romagnani S, Serio M & Romagnani P 2007 Role of chemokines in endocrine autoimmune diseases. Endocrine Reviews 28 492-520.
39. Schauer IG & Rowley DR 2011 The functional role of reactive stroma in benign prostatic hyperplasia. Differentiation 82 200-210.
40. Shigehara K, Sugimoto K, Konaka H, Iijima M, Fukushima M, Maeda Y, Mizokami A, Koh E, Origasa H, Iwamoto T et al. 2011 Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study. Aging Male 14 53-58.
41. Steiner GE, Stix U, Handisurya A, Willheim M, Haitel A, Reithmayr F, Paikl D, Ecker RC, Hrachowitz K, Kramer G et al. 2003a Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Laboratory Investigation 83 1131-1146.
42. Steiner GE, Newman ME, Paikl D, Stix U, Memaran-Dagda N, Lee C & Marberger MJ 2003b Expression and function of proinflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. Prostate 56 171-182.
43. Vignozzi L, Morelli A, Filippi S, Comeglio P, Chavalmane AK, Marchetta M, Toce M, Yehiely-Cohen R, Vannelli GB, Adorini L et al. 2011 Farnesoid X receptor activation improves erectile function in animal models of metabolic syndrome and diabetes. Journal of Sexual Medicine 8 57-77.
44. Vignozzi L, Morelli A, Sarchielli E, Comeglio P, Filippi S, Cellai I, Maneschi E, Serni S, Gacci M, CariniMet al. 2012 Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit. Journal of Endocrinology 212 71-84.
45. Welsh M, Moffat L, McNeilly A, Brownstein D, Saunders PT, Sharpe RM & Smith LB 2011 Smooth muscle cell-specific knockout of androgen receptor: a new model for prostatic disease. Endocrinology 152 3541-3451.
46. Zhang XH, Morelli A, Luconi M, Vignozzi L, Filippi S, Marini M, Vannelli GB, Mancina R, Forti G & Maggi M 2005 Testosterone regulatesPDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. European Urology 47 409-416.